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Patterns of medication prescription by dementia diagnosis in Australian nursing home 
residents: a cross-sectional study 
Abstract 
Aim 
To investigate medication use and associations with dementia diagnosis in Australian nursing 
home residents. 
Methods 
A cross-sectional study of 541 residents from 17 Australian nursing homes. 
Results 
Over 12 months each nursing home resident was prescribed an average of 14.5 (SD=6.8) 
medications. Approximately 95% of residents were prescribed medications for the nervous 
system 94% for the alimentary tract and metabolism. After adjustment for potential 
confounding factors, those with dementia were less likely to be prescribed medications for 
the cardiovascular system (OR=0.45, 95% CI: 0.27-0.77, p=0.0032) and respiratory system 
(OR=0.38, 95% CI: 0.25-0.60, p<0.0001).  Further analysis on specific medications showed 
that residents with dementia were more likely to be prescribed risperidone (OR=9.38, 95% CI: 
4.01-21.94, p<0.0001), buprenorphine (OR=3.37, 95% CI:1.78-6.36, p=0.0002), and 
trimethoprim (OR=1.78,95% CI:1.06-2.97,p=0.0282) but less likely to be prescribed glyceryl 
trinitrate (OR=0.42,95% CI:0.19-0.94,p=0.0340),  and salbutamol(OR=0.34,95% CI:0.2-
0.6,p=0.0002) in addition to other specific medications. 
Conclusions 
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Increased awareness of possible undertreatment of cardiovascular and respiratory conditions 
and possible overtreatment of urinary tract infection in those living with dementia in nursing 
home settings may improve management of this vulnerable population. 
Keywords: Prescribed Medicines, dementia, residential facilities, nursing home, aged. 
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Introduction 
The United Nations has estimated that that the population aged 60 years and above represents 
approximately 13 percent of the population worldwide in 2017 and this population is growing 
faster than all younger age groups.1 It is estimated that there are 1.2 billion older adults that 
suffer multimorbidity worldwide.2  Multimorbidity is common among older adults in 
developed nations, with data from 31 million United States (US ) Medicare claims indicating 
that 62% of those aged 65-74 years and 81.5% of those aged 85 years or over are living with 
two or more chronic conditions.3 In Australia, 74.6% of those aged 65-74 years  and 83.2% of 
those aged 75 years or older had multimorbidity.4 In the US, people aged 65 and above 
comprise about 13% of the population but they consume more than one third of all 
prescription medications.5  Multiple diseases and medication use will inevitably lead to 
polypharmacy, which is associated with inappropriate drug use, medication errors, poor 
compliance with mediation regimes, and adverse drug reactions.6  Concerningly, studies have 
shown that up to 50% of nursing home residents use nine or more drugs concurrently, putting 
this group at high risk of the poor outcomes associated with polypharmacy.7 
Cognitive impairment and dementia have previously been found to be associated with 
prescription medication use but the findings are inconsistent. A prospective cohort study 
conducted by Jyrkka et al found that excessive polypharmacy was associated with a decline 
of cognitive capacity.8 In contrast, a cross-sectional study conducted by Elseviers and 
colleagues found a marked decrease in prescriptions, particularly of pain-relieving 
medication among people living with dementia in Belgian nursing homes, which they 
highlighted as a potential concern.9   
We have conducted previous analyses within this study population which have demonstrated 
that prescription of cardiovascular medications is associated with lower probability of 
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dementia diagnosis, which raised questions about whether this may reflect general 
deprescribing of medications for residents with dementia.10 Therefore, we considered it 
important to investigate the  patterns of medication use among nursing home residents more 
extensively to see if there was a general trend across medication classes that may indicate 
likely deprescribing of mediations within residents living with dementia.  The purpose of this 
study is to investigate the patterns of medications prescribed for nursing home residents in 
Australia, considering a wide range of medication classes, within a cross-sectional study of 
17 nursing home facilities across four Australian states with extensive data collection on 
mediation use. In particular, we have examined whether there are differences in the usage of 
different medication classes in association with dementia diagnosis. 
Methods 
Study sample and design 
The study sample is from the Investigating Services Provided in the Residential Environment 
for Dementia (INSPIRED) study which is a cross-sectional study designed to determine and 
compare the quality of life, quality of care, utilization of healthcare resources and costs of 
nursing homes that provide alternative models of care for people with cognitive impairment 
and dementia. Data were collected from 17 not-for profit nursing homes across four 
Australian states between January 2015 and February 2016. The inclusion criteria for 
participants in INSPIRED were: (1) being permanent residents of the facility; (2) residing in 
the facility for 12 months or more; (3) not in immediate palliative care; (4) if not able to self-
consent, have family members who are able to provide proxy consent and/or participate on 
the resident’s behalf; and (5) no other complex medical or family issues that would prevent 
participation. Written informed consent was obtained from participants or their legal 
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guardians. Ethics approval for the study was obtained from the Flinders University social and 
research ethics committee.  
Medication use measurement 
Medication use data was of prescription and non-prescription medicines and was obtained 
from three sources: (1) pharmacy data records from nursing home-contracted pharmacists, or 
(2) facility-based medication charts when pharmacy data could not be obtained or (3) 
Pharmaceutical Benefits Scheme (PBS) data,11 provided by the Australian Government 
Department of Human Services. When available, pharmacy records were used as the primary 
data source and then facility-based medication charts, where these were not available PBS 
data was used. For each resident in the study the previous 12 months’ medication prescription 
data was collected, including prescription and supply date.  The number of different 
mediations prescribed over the 12 month period was determined, regardless of frequency of 
use. We grouped medications according to the Anatomical Therapeutic Chemical (ATC) 
classification system which is standardized system developed by the World Health 
Organization Collaborating Centre for Drug Statistics Methodology used world-wide for the 
categorization of drugs according to their activate ingredients and the organ system which 
they act upon.12  The ATC system classifies all medications into fourteen main groups (1st 
level): alimentary tract and metabolism (A), blood and blood forming organs (B), 
cardiovascular system (C), dermatologicals (D), genito-urinary system and sex hormones (G), 
systemic hormonal preparations, excluding sex hormones and insulins (H), antiinfectives for 
systemic use (J), antineoplastic and immunomodulating agents (L), musculo-skeletal system 
(M), nervous system (N), antiparasitic products, insecticides and repellents (P),respiratory 
system (R),sensory organs (S) and various (V).12  
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Dementia and comorbidity measures 
Diagnosis of dementia was collected from the residential facility’s medical records. 
According to the Australian Aged Care Act 1997 all nursing homes must keep records of 
nursing home residents’ medical conditions, the treatments they were receiving and the type 
of care that was being provided under a resident’s care plan.13 Data on comorbidities was 
determined by participants’ disease history as recorded in residential facility medical records.  
Statistical methods 
Means, standard deviations, frequencies and percentages were used to describe the sample. 
Chi-square test, t-test, and Fisher exact tests were used to compare the means and proportions 
across dementia diagnosis categories.  Logistic regression models were used to test 
associations between diagnosis of dementia and medications. First, unadjusted logistic 
regressions were conducted with one predictor variable (dementia yes vs. no) and a binary 
outcome variable that identified whether the resident used the class of medication or not.  
Then adjusted logistic regressions controlling for age, gender and unbalanced comorbidities 
(p<0.05 for dementia and non-dementia group) were conducted for each of the fourteen first 
level ATC medications. Unadjusted and adjusted logistic regressions were also used to 
further investigate the associations between top ten specific medications within each main 
group and dementia diagnosis. All statistical tests were two-sided tests. SAS 9.3 (SAS 
Institute, Cary, North Carolina, USA) was used to perform the analysis.  
Results 
In total, 1323 residents from the 17 facilities were assessed and 901 were eligible to 
participate, of these 541 consented (24% self-consent, 76% by proxy) to be part of the 
INSPIRED study.  The mean age was 85.5 years (SD=8.5), 74.5% were female and 64.3% 
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had been diagnosed dementia. The distributions of age, gender and comorbidities according 
to dementia status are summarized in Table 1. Those living with dementia were less likely to 
have comorbidities of airway diseases, angina, back pain, congestive cardiac failure, diabetes 
mellitus, dysphagia, hypertension, ischaemic heart disease, osteoarthritis, rheumatoid arthritis 
and stroke but were more likely to have faecal or urinary incontinence. 
Approximately 95% of participants were prescribed medications for the nervous system and 
approximately 94% residents were prescribed medications for alimentary tract and 
metabolism (Figure 1A). The next most common medication classes were those for the 
cardiovascular system (72.1%), antiinfectives for systemic use (68.9%) and dermatologicals 
(54.1%).  The most frequent co-morbidities were osteoarthritis (48.4%), hypertension 
(47.1%), depression (42.9%), urinary incontinence (39.2%) and faecal incontinence (22.5%) 
(Figure1B). 
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<Insert figure 1 here> 
During the previous twelve-month period nursing home residents were on average prescribed 
14.5 (SD= 6.8) different medications. Ninety-eight percent were prescribed more than five 
different medications and 71% were prescribed more than ten different medications over the 
12 month period (Figure 2A). These data do not represent concurrent use of medications. 
Over 12 months, on average nursing home residents with dementia were prescribed three 
fewer medications than nursing home residents without dementia (16.4 vs 13.4, p<0.0001). A 
higher proportion of residents with dementia were prescribed less than 15 medications over 
the 12 months while a higher proportion of residents without dementia were prescribed more 
than 16 medications (Figure 2B). 
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Unadjusted logistic regression models showed that diagnosis of dementia was associated with 
a lower probability of being prescribed medications for blood and blood forming organs, 
cardiovascular system, genito-urinary system and sex hormones, respiratory system and 
sensory organs but higher probability of being prescribed medications for antiparasitic 
products, insecticides and repellents (Figure 3). Adjusted logistic regression models 
controlling for age, gender, airway diseases, angina, back pain, congestive cardiac failure, 
diabetes mellitus, dysphagia, hypertension, ischaemic heart disease, osteoarthritis, 
rheumatoid arthritis ,stroke, faecal incontinence and  urinary incontinence showed that 
dementia was associated with lower probability of being prescribed medications for the 
cardiovascular system (OR=0.45, 95% CI:0.27-0.76, P=0.0031) and respiratory system 
(OR=0.39, 95% CI:0.25-0.60, P<0.0001)  but almost four times more likely to be prescribed 
antiparasitic products, insecticides and repellents, (OR=3.97, 95% CI:1.09-14.5, P=0.0369)  
(Figure 3).  
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Further analysis on the top ten specific medications within each main ATC group showed that 
nursing home residents with dementia were nine times more likely to be prescribed 
risperidone (OR=9.38, 95% CI: 4.01-21.94, p<0.0001) and three times more likely to be 
prescribed buprenorphine (OR=3.37, 95% CI:1.78-6.36, p=0.0002). Residents with dementia 
were also more likely to be prescribed macrogol combinations (OR=1.68,95% CI:1.11-
2.55,p=0.0137) and trimethoprim (OR=1.78, 95% CI:1.06-2.97, p=0.0282) but less likely to 
be prescribed esomeprazole (OR=0.36,95% CI:0.21-0.62, p=0.0003), atorvastatin 
(OR=0.55,95% CI:0.31-0.99,p=0.0444), metoprolol(OR=0.45,95% CI:0.24-0.87, p=0.0173), 
amlodipine(OR=0.34,95% CI:0.16-0.72, p=0.0049), glyceryl trinitrate (OR=0.42,95% 
CI:0.19-0.94,p=0.0340), atenolol(OR=0.31,95% CI:0.14-0.67,p=0.0029), 
salbutamol(OR=0.34,95% CI:0.2-0.6,p=0.0002) and bromhexine (OR=0.18,95% CI:0.06-
0.50,p=0.0011) (Appendix table s1 to table s14). 
Discussion 
This study has shown that there are significant differences in the prescription of medications 
for those with a dementia diagnosis amongst nursing home residents, following adjustment 
for differences in comorbidities between those with and without dementia. Residents with 
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dementia had a lower probability of being prescribed certain medications used for the 
management of cardiovascular and respiratory disease and an increased probability of use of 
some nervous system, antiinfectives and antiparasitic medications.  
Within the classes of cardiovascular and respiratory disease medications, it is noteworthy that 
there was significantly reduced use of medications that can be considered as used for 
symptomatic management (for example, salbutamol, glyceryl trinitrate) by those diagnosed 
with dementia, whereas the use of other medications that are not used PRN (pro re nata, for 
example, tiotropium, fluticasone, furosemide) did not significantly differ. This is likely to 
reflect reduced awareness of, or ability to communicate symptoms by those residents living 
with dementia.14  
Unsurprisingly, residents diagnosed with dementia were more likely to be prescribed 
medications that are likely to be used for the management of behavioural and psychological 
symptoms of dementia (BPSD). Those living with dementia were nine times more likely to 
be prescribed the antipsychotic risperidone. Globally, clinical practice guidelines recommend 
the avoidance of use of antipsychotics for the management of BPSD wherever possible, due 
to the increased risk of cerebrovascular adverse events and death.15 Our study demonstrated 
that one quarter of nursing home residents with dementia had been prescribed risperidone, 
suggesting that this medication is likely to be over prescribed. The high prevalence of use of 
this mediation indicates that it is unlikely that risperidone is being used only for the 
management of symptoms that place the residents or others at significant risk of harm. These 
findings are consistent with those of others, a high rate of use of antipsychotics in nursing 
home residents with has been reported previously.16 
Buprenorphine is an opioid used for treating pain. In this study, residents with dementia were 
three times more likely to be prescribed buprenorphine than those without dementia. Pain has 
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been reported to be observed more often in residents with severe dementia and pain severity 
was significantly correlated with dementia severity.17 A randomized trial (RCT) has 
demonstrated the efficacy of treating pain in the management of BPSD.18 In this study, 
nursing home residents with moderate to severe BPSD were treated with a stepped pain 
management protocol, including paracetamol, morphine, buprenorphine or pregabaline. 
Residents with swallowing difficulties received buprenorphine via a transdermal patch. The 
trial found significant reductions in agitation and the severity of overall neuropsychiatric 
symptoms. The increased use of buprenorphine observed in in the residents with dementia the 
INSPIRED study may be due to the management of BPSD.18 Equally, the increased use of 
buprenorphine may be due to the ease of administration via a patch. However, it is notable 
that a significant increase in fentanyl use, which is also administered by patch, was not 
observed. There was in fact a non-significant reduction in the use of fentanyl as well as 
oxycodone. Whilst our analysis does not indicate whether or not there is a difference in the 
total opioid use, it is unlikely that differential prescription of opioids used less frequently 
explains the increase in buprenorphine use. 
An increase in the prescription of trimethoprim was also observed in residents with dementia, 
after adjustment for differences in comorbidities including urinary incontinence. This 
antibiotic is commonly used for the treatment of urinary tract infections. The reason for this 
increased use cannot be determined, however it is possible that greater confusion or 
worsening cognition in residents with dementia is attributed to urinary tract infections, 
prompting treatment or increased testing for urinary tract infections. Other studies have 
shown that a high proportion of urinary tract infections (UTIs) in nursing home residents, 
especially for the residents with advanced dementia, were misdiagnosed.19 
Other differences in medication use between those with and without dementia that were 
observed were an increase in the prescription of macrogol combinations for those with 
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dementia. This may possibly be in association with the increased prescription of 
buprenorphine. In addition, there was decreased use of some dermatologicals in those with 
dementia, however the reasons for this is unclear.   
Nursing home residents with dementia were almost four times more likely to be prescribed 
the antiparasitic products in our study, although the prevalence of these prescriptions was low. 
In nursing home settings, these products are mostly used to treat for scabies. Scabies has been 
shown to be strongly associated with nursing home residents with dementia and it is still a 
challenge for caring residents with dementia in nursing homes.19,20 
Polypharmacy is common among the nursing home residents with the prevalence of 
polypharmacy in nursing homes varying widely from 15% to more than 90% depending on 
the definition used.22-24   Our study showed that over a 12 month period on average each 
resident was prescribed 14.5 different medications. This is much higher than most estimates 
of polypharmacy in other studies, but this figure from our study does not indicate the use of 
concurrent medications as it reflects total use over a 12 month period.  
Common interventions to improve optimal prescribing practices for people living in nursing 
homes include medication reviews and educational interventions. Medication management 
reviews for nursing home residents are available in Australia and the need for a review can be 
identified by the resident, a family member or someone involved in the healthcare of the 
resident (e.g. staff of the nursing home, GP or pharmacist).25 A recent systematic review 
concluded that medication reviews conducted by pharmacists or a multidisciplinary team 
appear to reduce the number of prescribed medications, the number of potentially 
inappropriate medications (PIMs) and adverse effects including hospitalizations and 
mortality.26 We have demonstrated that the use of potentially inappropriate medications were 
associated with quality of  life in older adults living in nursing homes with a high prevalence 
14 
 
of cognitive impairment and dementia.27 Awareness by pharmacy and healthcare staff of the 
medication patterns observed in this study are important, as people living with dementia may 
be getting respiratory and cardiovascular symptoms undertreated, in addition to the possible 
overuse of antipsychotics which is likely to be associated with poorer quality of life.  
This interpretation of findings of this study are limited by the cross-sectional design which 
does not allow examination of the temporal sequence of observed associations. The data did 
not allow for analysis based on different subtypes of dementia which might be associated 
with different mediation uses (in particular for the management of BPSD).  The list of 
comorbidities obtained from the medical records were not restricted to the disease experience 
of the participants over the previous 12 months so some conditions may not be current. A 
significant strength of this study was the use of dispensing data from individual pharmacy 
records, which are inclusive of all medications dispensed for the residents whilst at the 
facility. Alternative sources of medication data were used where this data was not available. 
Therefore, data on medications are considered highly accurate. However, the gold standard 
for measuring medication use is to examine the medication charts of the participants, but this 
was not feasible in this study.  Using dispensing data from pharmacy records allowed a 
systematic exploration of the full spectrum of prescription medications and their associations 
with dementia by ATC classifications. 
In summary, in this study the majority of nursing home resident were prescribed medications 
for nervous system and for the alimentary tract and metabolism over a 12 month period. 
Multiple mediation use was common for both dementia and non-dementia residents. 
Residents with dementia had significantly greater use of medications for the treatment of 
BPSD (including buprenorphine) and urinary tract infections. In contrast, drugs that were 
commonly used for the treatment of symptoms in the respiratory, cardiovascular and 
gastrointestinal systems were used significantly less frequently. Medications used for 
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prevention in cardiovascular disease management such as atorvastatin and metoprolol were 
also used less often. Awareness by pharmacy and healthcare staff of likely overuse of 
antipsychotics, potential undertreatment of cardiovascular and respiratory symptoms and 
possible overtreatment of urinary tract infection in those living with dementia in a nursing 
home population may improve management and quality of life in this vulnerable population.  
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Table 1 Characteristics of study sample by dementia status   
Characteristics 
Without dementia With dementia 
P value 
n=193* n=348 
Age(Mean, SD) 86.1(9.2) 85.1(8.1) 0.2151 
Female (n, %) 147(76.2) 256(73.6) 0.5059 
Different number of medication used (Mean, SD) 16.4(7.4) 13.4(6.2) <0.0001 
Comorbidities (n, %) 
    Airways Disease 50(26.2) 53(15.2) 0.0020 
 Anaemia 13(6.8) 14(4.0) 0.1565 
 Angina 14(7.6) 12(3.5) 0.0443 
 Back Pain 37(19.4) 44(12.6) 0.0365 
 Congestive Cardiac failure 25(13.0) 18(5.2) 0.0012 
 Chronic Renal Failure 12(6.3) 15(4.3) 0.3153 
 Cancer 37(19.4) 62(17.8) 0.6555 
 Constipation 18(9.4) 40(11.5) 0.4582 
 Deep Vein Thrombosis 3(1.6) 2(0.57) 0.2486 
 Deafness 30(15.7) 43(12.4) 0.2769 
 Depression 89(46.6) 142(40.8) 0.1937 
 Diabetes Mellitus 54(28.3) 59(17.0) 0.0020 
 Diahorrea 2(1.1) 2(0.57) 0.5410 
 Dysphagia 14(7.3) 12(3.5) 0.0443 
 Falls 20(10.5) 49(14.1) 0.2303 
 Faecal Incontinence 21(11.0) 100(28.7) <0.0001 
 Gastro-Oesophageal Reflux Disorder 39(20.5) 51(14.7) 0.0861 
 Hypertension 110(57.6) 144(41.4) 0.0003 
 Hypercholesterolaemia 51(26.7) 69(19.8) 0.0665 
 Hyperthyroid 4(2.1) 11(3.2) 0.4714 
 Hypothyroid 17(8.9) 28(8.1) 0.7316 
 Ischaemic Heart Disease 47(24.6) 60(17.2) 0.0403 
Osteoarthritis 105(55.0) 156(44.8) 0.0242 
Osteoporosis 42(22.0) 76(21.8) 0.9678 
 Parkinson's Disease 12(6.3) 13(3.7) 0.1787 
 Rheumatoid Arthritis 13(6.8) 10(2.9) 0.0307 
 Stroke 49(25.7) 51(14.7) 0.0017 
 Urinary Incontinence 62(32.5) 149(42.8) 0.0185 
 Urinary Tract Infection 28(14.7) 40(11.5) 0.2897 
*including 6 missing values for residents whose medical records did not indicate dementia diagnosis or not 
 
 
 
 
 
 
 
